These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9245192)

  • 21. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
    Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
    Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.
    Theodorakis GN; Markianos M; Zarvalis E; Livanis EG; Flevari P; Kremastinos DT
    J Am Coll Cardiol; 2000 Jul; 36(1):174-8. PubMed ID: 10898430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
    Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal neuroendocrine responsivity to clomipramine in depression.
    Golden RN; Ruegg R; Brown TM; Haggerty J; Garbutt JC; Pedersen CA; Evans DL
    Psychopharmacol Bull; 1990; 26(3):317-20. PubMed ID: 2125736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
    Golden RN; Hsiao JK; Lane E; Ekstrom D; Rogers S; Hicks R; Potter WZ
    Psychiatry Res; 1990 Jan; 31(1):39-47. PubMed ID: 2156276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central serotonergic changes following antidepressant treatment: a neuroendocrine assessment.
    Leatherman ME; Ekstrom RD; Corrigan M; Carson SW; Mason G; Golden RN
    Psychopharmacol Bull; 1993; 29(2):149-54. PubMed ID: 8290659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
    Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM; O'Keane V; Murray RM
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.
    Shapira B; Yagmur MJ; Gropp C; Newman M; Lerer B
    Biol Psychiatry; 1992 May; 31(10):975-83. PubMed ID: 1511080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of intravenous clomipramine on neurohormones in normal subjects.
    Golden RN; Hsiao J; Lane E; Hicks R; Rogers S; Potter WZ
    J Clin Endocrinol Metab; 1989 Mar; 68(3):632-7. PubMed ID: 2537340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersensitivity of the corticotropic axis to the serotoninergic agent clomipramine in obese women.
    Laferrère B; Lahlou N; Saltiel H; Roger M; Basdevant A; Oppert JM; Guy-Grand B
    Obes Res; 1994 Jul; 2(4):328-36. PubMed ID: 16353581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery from major depression is not associated with normalization of serotonergic function.
    Flory JD; Mann JJ; Manuck SB; Muldoon MF
    Biol Psychiatry; 1998 Mar; 43(5):320-6. PubMed ID: 9513746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.
    Heninger GR; Charney DS; Sternberg DE
    Arch Gen Psychiatry; 1984 Apr; 41(4):398-402. PubMed ID: 6703856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
    Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
    Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are gender differences important for the clinical effects of antidepressants?
    Hildebrandt MG; Steyerberg EW; Stage KB; Passchier J; Kragh-Soerensen P;
    Am J Psychiatry; 2003 Sep; 160(9):1643-50. PubMed ID: 12944340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clomipramine enhances prolactin and growth hormone responses to L-tryptophan.
    Anderson IM; Cowen PJ
    Psychopharmacology (Berl); 1986; 89(1):131-3. PubMed ID: 3016787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.